search
Back to results

Surviving PEA in Roanoke (SPEAR) Study (SPEAR)

Primary Purpose

Cardiac Arrest, Pulseless Electrical Activity

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
High Calcium, Low Sodium (HCLS) Crystalloid Therapy
High Calcium, High Sodium (HCHS) Crystalloid Therapy
Sponsored by
Carol Bernier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest focused on measuring Crystalloid Fluids, Emergency Medical Services (EMS), Pre-Hospital Medicine, Sodium Chloride, Calcium Chloride, Normal Saline, Half-Normal Saline, Waiver of Informed Consent, Paramedic, Electrolyte

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients who present with PEA at any time during the patients' treatment by Roanoke Fire-EMS, Botetourt County Department of Fire & EMS and/or Salem Fire-EMS. This study defines a PEA presentation as any patient who is unconscious, presenting without a carotid pulse and with non-(VT/VF) ventricular tachycardia/ventricular fibrillation electrical activity.

Exclusion Criteria:

  • Patient less than 18 years old
  • Known pregnancy
  • Duration of untreated cardiac arrest of more than 30 minutes
  • Traumatic cardiac arrest
  • Known (LVAD) Left Ventricular Assist Device
  • Rapidly fatal underlying disease
  • Known or suspected digitalis toxicity
  • A physical, durable (DNR) Do Not Resuscitate (or durable DNR medical jewelry) presented to EMS before treatment with asserting a preference not to be enrolled
  • Prisoners and other populations with involuntary consent

Sites / Locations

  • Carilion ClinicRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

High-Calcium, High- Sodium (HCHS) group

High-Calcium, Low- Sodium (HCLS) group

Arm Description

Patients will receive a drip of blinded, intravenous, normal saline and an unblinded, intravenous, one gram bolus of calcium chloride.

Patients will receive a drip of blinded, intravenous, half-normal saline and an unblinded, intravenous, one gram bolus of calcium chloride.

Outcomes

Primary Outcome Measures

Event Survival
ROSC sustained until arrival at the emergency department and transfer of care to medical staff at the receiving hospital?

Secondary Outcome Measures

Any Return-Of-Spontaneous-Circulation (ROSC)
Did the patient achieve ROSC at any point during the resuscitation attempt?
Survival to hospital discharge
Did the patient survive to hospital discharge?
Neurological outcome at hospital discharge
(CPC) Cerebral Performance Category Score and/or (mRS) modified Rankin Score at hospital discharge?
Serum Electrolyte Values
All (BMP) Basic Metabolic Panel values will be collected, but there is a particular emphasis on serum sodium and calcium values.

Full Information

First Posted
February 20, 2022
Last Updated
March 8, 2022
Sponsor
Carol Bernier
Collaborators
Virginia Polytechnic Institute and State University
search

1. Study Identification

Unique Protocol Identification Number
NCT05283850
Brief Title
Surviving PEA in Roanoke (SPEAR) Study
Acronym
SPEAR
Official Title
A Prospective, Pre-Hospital Comparison of Normal Saline Versus Half-Normal Saline, After Universal Calcium Chloride Administration, to Improve Outcomes in Pulseless Electrical Activity Patients
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 16, 2022 (Actual)
Primary Completion Date
February 2027 (Anticipated)
Study Completion Date
February 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Carol Bernier
Collaborators
Virginia Polytechnic Institute and State University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The Carilion Clinic and Virginia Tech Carilion School of Medicine, in conjunction with Roanoke Fire-EMS, Botetourt County Department of Fire & EMS and Salem Fire-EMS, are studying the outcomes of patients experiencing Pulseless Electrical Activity (PEA). PEA refers to a type of cardiac arrest in which there is normal electrical activity in the heart however the heart still fails to contract to generate a pulse. Without heart contractions, which normally generates a pulse, the brain and other important organs fail to receive blood and oxygen. Unfortunately, the majority (97.3%) of patients that experience this rhythm do not survive and most don't even make it to the hospital. This study is trying to determine if the administration of a High Calcium, Low Sodium (HCLS) fluid in pre-hospital care will improve the chances of survival. Generally, a sodium (salt) solution is provided to patients experiencing cardiac arrest. Studies have shown that lower sodium and higher calcium content may activate certain parts of the heart cells required to generate a pulse under PEA conditions. This study is a double-blind, prospective, clinical trial. PEA patients will randomly receive either routine fluid therapy (salt solution) or a HCLS solution. While HCLS solution is not the standard fluid used by EMS providers responding to PEA, it is composed of FDA approved components and is occasionally used by EMS providers at their discretion in treating PEA. It is predicted that HCLS will either improve PEA survival or deliver similar outcomes as routine treatment. All patients will receive standard, high quality cardiac arrest and post-cardiac arrest care regardless of assigned treatment group.
Detailed Description
Pursuant to a Waiver of Informed Consent, this investigation will automatically enroll all eligible PEA patients treated by Roanoke Fire-EMS, Botetourt County Department of Fire & EMS and/or Salem Fire-EMS systems. Once patients are enrolled, they will be de-facto randomized into one of two groups: control High Calcium-High Sodium (HCHS) or interventional High Calcium-Low Sodium (HCLS). Supervisors will have on their trucks, numbered-but-otherwise-blinded bags of half-normal saline or normal saline solution. The bags will be numbered, recorded and randomized by this study's investigators. Supervisors, when providing care, will universally administer 1g unblinded CaCl2 and then subsequently chose a crystalloid fluid set to use from their trucks randomly. The crystalloid will be administered as a wide open IV drip at a rate of at least 1000ml/hour, depending on gauge size, for as long as fluids are indicated for, likely resulting in a crystalloid dose of 0.5-2(L) liters. Each bag-set will have two bags of the same blinded unit to allow for treatment with up to (2L) 2 liters of fluid for a patient. Explicitly, all enrolled patients will be receiving calcium, it is only the crystalloid fluid (normal saline vs half-normal saline) that will differ. HCLS treatment was designed to be hyponatremic compared to normal saline (while both groups in this trial will be hypercalcemic compared to pure normal saline PEA therapy) in order to initiate low sodium inotropy. The contents of the bag will be blinded to the supervisor. Neither the patient nor the supervisor will know which treatment was given thus ensuring double-blinding. Further, by randomly choosing a bag with no knowledge of its contents, the treatment will effectively be randomized. Both groups will otherwise receive current routine Advanced Cardiac Life Support and either standard post-arrest care or standard termination of care. Per Roanoke Fire-EMS, Botetourt County Department of Fire & EMS and Salem Fire-EMS standard protocol, only patients who undergo ROSC on scene will be transported to a hospital.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest, Pulseless Electrical Activity
Keywords
Crystalloid Fluids, Emergency Medical Services (EMS), Pre-Hospital Medicine, Sodium Chloride, Calcium Chloride, Normal Saline, Half-Normal Saline, Waiver of Informed Consent, Paramedic, Electrolyte

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Patients, being intrinsically unconscious from PEA, will be blinded to the intervention. EMS Supervisors, in the pre-hospital setting, will administer an opaque bag of fluids with only a bag number on it, ensuring that they are blinded to the intervention. Hospital providers/outcomes assessors will know that patients were enrolled in a study and they will only know which bag number was used. The investigator will have the capacity to unblind bag numbers, but the investigator will not be the provider or outcomes assessor for patients due to the emergent nature of PEA.
Allocation
Randomized
Enrollment
342 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High-Calcium, High- Sodium (HCHS) group
Arm Type
Active Comparator
Arm Description
Patients will receive a drip of blinded, intravenous, normal saline and an unblinded, intravenous, one gram bolus of calcium chloride.
Arm Title
High-Calcium, Low- Sodium (HCLS) group
Arm Type
Experimental
Arm Description
Patients will receive a drip of blinded, intravenous, half-normal saline and an unblinded, intravenous, one gram bolus of calcium chloride.
Intervention Type
Drug
Intervention Name(s)
High Calcium, Low Sodium (HCLS) Crystalloid Therapy
Other Intervention Name(s)
(NDC) National Drug Code NDC 0264-7800-00 and NDC 0409-4928-11
Intervention Description
Half-normal saline IV drip and 1g IV bolus Calcium Chloride.
Intervention Type
Drug
Intervention Name(s)
High Calcium, High Sodium (HCHS) Crystalloid Therapy
Other Intervention Name(s)
NDC NDC 0264-7802-00 and NDC 0409-4928-11
Intervention Description
Normal saline IV drip and 1g IV bolus Calcium Chloride.
Primary Outcome Measure Information:
Title
Event Survival
Description
ROSC sustained until arrival at the emergency department and transfer of care to medical staff at the receiving hospital?
Time Frame
Up to 1 hour
Secondary Outcome Measure Information:
Title
Any Return-Of-Spontaneous-Circulation (ROSC)
Description
Did the patient achieve ROSC at any point during the resuscitation attempt?
Time Frame
Through resuscitation efforts up to 1 hour after arrival to (ED) Emergency Department
Title
Survival to hospital discharge
Description
Did the patient survive to hospital discharge?
Time Frame
Up to 30 days after admission to (ED) Emergency Department
Title
Neurological outcome at hospital discharge
Description
(CPC) Cerebral Performance Category Score and/or (mRS) modified Rankin Score at hospital discharge?
Time Frame
Up to 30 days after admission to ED
Title
Serum Electrolyte Values
Description
All (BMP) Basic Metabolic Panel values will be collected, but there is a particular emphasis on serum sodium and calcium values.
Time Frame
Up to 12 hour after admission to the (ED) Emergency Department

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients who present with PEA at any time during the patients' treatment by Roanoke Fire-EMS, Botetourt County Department of Fire & EMS and/or Salem Fire-EMS. This study defines a PEA presentation as any patient who is unconscious, presenting without a carotid pulse and with non-(VT/VF) ventricular tachycardia/ventricular fibrillation electrical activity. Exclusion Criteria: Patient less than 18 years old Known pregnancy Duration of untreated cardiac arrest of more than 30 minutes Traumatic cardiac arrest Known (LVAD) Left Ventricular Assist Device Rapidly fatal underlying disease Known or suspected digitalis toxicity A physical, durable (DNR) Do Not Resuscitate (or durable DNR medical jewelry) presented to EMS before treatment with asserting a preference not to be enrolled Prisoners and other populations with involuntary consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cara Spivy, MS
Phone
540-676-7965
Email
crspivey@carilionclinic.org
First Name & Middle Initial & Last Name or Official Title & Degree
William Reis, MS
Email
wrreis@carilionclinic.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carol Bernier, DO
Organizational Affiliation
Virginia Polytechnic Institute and State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Carilion Clinic
City
Roanoke
State/Province
Virginia
ZIP/Postal Code
24014
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carol Bernier, DO
Phone
540-293-6352
Email
cabernier@carilionclinic.org

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Unidentified data could be arranged to be shared with researchers who specifically request it, but this study is not currently (IRB) Institutional Review Board approved to do so.

Learn more about this trial

Surviving PEA in Roanoke (SPEAR) Study

We'll reach out to this number within 24 hrs